Ticker name:ASNDAscendis Pharma A/S
Country: DK-Sector: Healthcare, Industry: Biotechnology
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
- CEO: Jan Moller Mikkelsen
- IPO: Jan 28, 2015
- Website:...ndispharma.com (open a new tab)
Market Cap 16B
Last close 251.76$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 122B | 480.5$ | |
| 2 | REGN | REGENERON PHARMACEUTICALS, INC. | 70B | 672.15$ | |
| 3 | RVMD | Revolution Medicines, Inc. | 38B | 180.39$ | |
| 4 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 36B | 272.67$ | |
| 5 | ROIV | Roivant Sciences Ltd. | 24B | 34.05$ | |
| 6 | MRNA | Moderna, Inc. | 24B | 59.49$ | |
| 7 | INSM | INSMED Inc | 23B | 107.02$ | |
| 8 | INCY | INCYTE CORP | 23B | 115.65$ | |
| 9 | UTHR | UNITED THERAPEUTICS Corp | 22B | 529.34$ | |
| 10 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 173$ | |
| 11 | BBIO | BridgeBio Pharma, Inc. | 16B | 80.76$ | |
| 12 | ASND | Ascendis Pharma A/S | 16B | 251.76$ | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | 15B | 243.47$ | |
| 14 | EXEL | EXELIXIS, INC. | 14B | 55.53$ | |
| 15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | 12B | 535.69$ | |
| 16 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 59.11$ | |
| 17 | AXSM | Axsome Therapeutics, Inc. | 11B | 221.64$ | |
| 18 | TECH | BIO-TECHNE Corp | 11B | 71.64$ | |
| 19 | SMMT | Summit Therapeutics Inc. | 10B | 13.5$ | |
| 20 | APGE | Apogee Therapeutics, Inc. | 10B | 134.15$ |